Renal artery stenosis resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Line 36: | Line 36: | ||
<tr><td>9. Refractory angina</td><td>Class IIb; LOE C</td></tr> | <tr><td>9. Refractory angina</td><td>Class IIb; LOE C</td></tr> | ||
</table>}} | </table>}} | ||
{{familytree | | | |!| | | | | | | | | | | }} | |||
{{familytree | | | A01 | | | A01= Proceed to further diagnostic testing'''}} | |||
{{familytree | | | |!| | | | | | | | | | | }} | |||
{{familytree | |,|-|^|-|.| | }} | {{familytree | |,|-|^|-|.| | }} | ||
{{familytree | B01 | | B02 | B01=<div style="height: 1em; width: 25em; padding:1em;">''' | {{familytree | B01 | | B02 | B01=<div style="height: 1em; width: 25em; padding:1em;">'''Noninvasive Imaging''' | ||
*Duplex ultrasound | |||
*Gadolinium enhanced MRA | |||
*CT angiography''' </div>| B02= <div style="height: 1em; width: 25em; padding:1em;">'''Invasive Imaging''' | |||
*Abdominal aortography to assess the renal arteries during coronary and peripheral angiography</div>}} | |||
{{familytree | |!| | | |!| | }} | {{familytree | |!| | | |!| | }} |
Revision as of 06:03, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
Definition
This section provides a short and straight to the point definition of the disease or symptom in one sentence.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Clinical Clues to the Diagnosis of RAS
❑ Determine if one or more of the above is present | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
Proceed to further diagnostic testing | |||||||||||||||||||||||||||||||
Noninvasive Imaging
| Invasive Imaging
| ||||||||||||||||||||||||||||||
❑ Do not monitor platelet count | ❑ Monitor platelet count every 2 or 3 days from day 4 to day 14 (or until heparin is stopped) | ||||||||||||||||||||||||||||||
Algorithm based on the 2012 ACCP evidence based clinical practice guidelines.[1]
References
- ↑ Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S; et al. (2012). "Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. 141 (2 Suppl): e495S–530S. doi:10.1378/chest.11-2303. PMC 3278058. PMID 22315270.